Keysight Technologies Adds Charles Dockendorff to Board

Keysight Technologies reported plans to appoint Charles J. Dockendorff to its board of directors.

According to a release from the Company, Dockendorff is executive vice president and chief financial officer of Covidien where he is responsible for the company's financial management and activities, including corporate accounting, tax, treasury, financial planning and investor relations, as well as internal audit and information services. He has held the position at Covidien and its predecessor, Tyco Healthcare, since 1995.

Dockendorff joined Kendall Healthcare Products in 1989 as controller. He previously, held leadership positions at Epsco, Inc. and Infrared Industries. Dockendorff also worked as an accountant at Arthur Young & Company (now Ernst & Young) and the General Motors Corp.

"Chuck Dockendorff is a highly-respected leader with extensive experience in financial management and will be an excellent addition to our board as Keysight becomes independent from Agilent," said Paul Clark, chairman-designate of Keysight's board of directors. "Chuck's experience in helping Tyco Healthcare grow sales from $600 million in 1995 to more than $10 billion when Covidien was spun off as a separate public company, as well as his experience with the spinoff company thereafter, makes him an excellent addition to Keysight's growing board."

Keysight expects Dockendorff's appointment to become effective concurrently with, or shortly before, the completion of the Keysight spinoff, currently targeted for November 2014.

Keysight is a global electronic measurement technology company.

More information and complete details:

www.keysight.com

((Comments on this story may be sent to newsdesk@closeupmedia.com))